The Body Covers: The XIII International AIDS Conference
The Prevalence of Hypogonadism in HIV-Infected Patients Receiving HAART
Coverage provided by Alvan Fisher, M.D.
July 11, 2000
This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document.
- The prevalence of hypogonadism in HIV-infected patients receiving HAART (Poster Presentation TuPeB3180)
Authored by M. Desyatnik, A. Baaj, A. Fisher (United States)
In this study we did a retrospective chart review of 88 male patients with HIV infection who had been on HAART for at least six months. Hypogonadism as defined by low serum-free testosterone (<15 pg/ml) was seen in 20%. Clinical wasting (weight loss >5% of ideal body weight) was prevalent in 42%. Hypogonadism was seen in 14% of patients without wasting and 30% of patients with clinical wasting. Also the majority of patients with moderate or severe wasting were not hypogonadal, but testosterone deficiency was seen more often in patients with more than moderate wasting.
We concluded that testosterone deficiency in these male patients was lower than previously reported in other cohorts and did not correlate with wasting. Indeed, wasting may be the cause of testosterone deficiency.
This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document.
This article was provided by The Body PRO. Copyright © Body Health Resources Corporation. All rights reserved.
|
Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.
|
